Testing whether adjusting ECT treatment helps depression outcomes
Part of Mental health clinical trials.
This study tests a way of adjusting (titrating) ECT treatment to improve outcomes in people with major depression or bipolar II. It’s mainly for those who already need ECT with right-side electrode placement.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with major depressive disorder or bipolar II
- Your doctor has said you need ECT using right unilateral electrode placement
- You do not have neurological or brain disease conditions such as traumatic brain injury, epilepsy, or Alzheimer’s
- You do not have other major psychiatric illnesses like schizophrenia or bipolar I disorder
- You do not currently have a drug or alcohol use disorder (nicotine is allowed)
- You are able to safely have an MRI scan (no MRI contraindications)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies better ways to deliver ECT (electroconvulsive therapy) for people with difficult-to-treat depression, including some people with bipolar depression. You may be offered an ECT strategy that’s tailored to your situation, with the goal of improving outcomes and reducing problems.
This study measures changes in your blood and/or body chemistry while you receive electroconvulsive therapy (ECT) for a severe mood episode. The goal is to understand biological signals related to ECT and treatment-resistant depression, which may help improve future care.
This study looks at how to best set the electrical stimulation for electroconvulsive therapy (ECT), a treatment for severe depression and other mental health conditions. The goal is to improve how well ECT works while possibly reducing side effects.
This study tests whether adding TMS to ECT can better treat depression that hasn't improved with other treatments. It is for adults with moderate to severe major depression who haven't had these treatments recently.
This trial studies which electrical “pulse settings” work best during electroconvulsive therapy (ECT) for people with depression. It may help doctors personalize ECT so the treatment is safer and works as well as possible for you.
This trial tests a new type of seizure therapy (low amplitude pulse seizure therapy) against the standard ultra-brief right unilateral ECT for people with severe depression, including those with suicidal thoughts. The goal is to see which treatment works better.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.